Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models

References

• Quindós G, Marcos-Arias C, San-Millán R, et al. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris. Int Microbiol. 2018;21(3):107–119.
   PubMed Web of Science ®Google Scholar
• Sabino R, Veríssimo C, Áa P, et al. Candida auris, an agent of hospital-associated outbreaks: Which challenging issues do we need to have in mind? Microorganisms. 2020;8(2):181.
   Web of Science ®Google Scholar
• Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;2017(64):134–140.
   Google Scholar
• Arikan-Akdagli S, Ghannoum M, Meis JF. Antifungal resistance: specific focus on multidrug resistance in Candida auris and secondary azole resistance in Aspergillus fumigatus. J Fungi. 2018;4(4):129.
   Web of Science ®Google Scholar
• Ruiz-Gaitán A, Moret AM, Tasias-Pitarch M, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses. 2018;61(7):498–505.
   PubMed Web of Science ®Google Scholar
• Chow NA, Muñoz JF, Gade L, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. MBio. 2020;11(2):e03364–19.
   PubMed Web of Science ®Google Scholar
• Chow NA, De Groot T, Badali H, et al. Potential Fifth Clade of Candida auris, Iran, 2018. Emerg Infect Dis. 2019;25(9):1780–1781.
   PubMed Web of Science ®Google Scholar
• Muñoz JF, Gade L, Chow NA, et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun. 2018;9(1):1–13.
   PubMedGoogle Scholar
• Chybowska AD, Childers DS, Farrer RA. Nine things genomics can tell us about Candida auris. Front Genet. 2020;11(April):1–18.
   PubMedGoogle Scholar
• Kean R, Delaney C, Sherry L, et al. Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance. mSphere. 2018;3(4):e00334–18.
   PubMed Web of Science ®Google Scholar
• Muñoz JE, Ramirez LM, Dias LDS, et al. Pathogenicity levels of Colombian strains of Candida auris and Brazilian strains of Candida haemulonii species complex in both murine and Galleria mellonella experimental models. J Fungi (Basel). 2020;6(3):E104.
   PubMedGoogle Scholar
• Brown JL, Delaney C, Short B, et al. Candida auris phenotypic heterogeneity determines pathogenicity in vitro. mSphere. 2020;5(3):e00371–20.
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Berman J, Novikov A, et al. Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis. 2017;23(2):195–203.
   PubMed Web of Science ®Google Scholar
• Fakhim H, Vaezi A, Dannaoui E, et al. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Mycoses. 2018;61(6):377–382.
   PubMed Web of Science ®Google Scholar
• Yue H, Bing J, Zheng Q, et al. Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch. Emerg Microbes Infect. 2018;7(1):1.
   PubMed Web of Science ®Google Scholar
• Kean R, Brown J, Gulmez D, et al. Candida auris: a decade of understanding of an enigmatic pathogenic yeast. J Fungi. 2020;6(1):30.
   Web of Science ®Google Scholar
• Torres SR, Pichowicz A, Torres-Velez F, et al. Impact of Candida auris infection in a neutropenic murine model. Antimicrob Agents Chemother. 2020;64(3):e01625–19.
   PubMed Web of Science ®Google Scholar
• Bruno M, Kersten S, Bain JM, et al. Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris. Nat Microbiol. 2020;5(12):1516–1531.
   PubMed Web of Science ®Google Scholar
• Kumar A, Baruah A, Tomioka M, et al. Caenorhabditis elegans: a model to understand host–microbe interactions. Cell Mol Life Sci. 2019. DOI:10.1007/s00018-019-03319-7.
   Web of Science ®Google Scholar
• Jemel S, Guillot J, Kallel K, et al. Galleria mellonella for the evaluation of antifungal efficacy against medically important fungi, a narrative review. Microorganisms. 2020;8(3):390.
   PubMed Web of Science ®Google Scholar
• Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere. 2016;1(4):4–6.
   Web of Science ®Google Scholar
• Sherry L, Ramage G, Kean R, et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017;23(2):328–331.
   PubMed Web of Science ®Google Scholar
• Eldesouky HE, Li X, Abutaleb NS, et al. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris. Int J Antimicrob Agents. 2018;52(6):754–761.
   PubMed Web of Science ®Google Scholar
• Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China: Clinical and biological aspects article. Emerg Microbes Infect. 2018;7(1):0–8.
   Google Scholar
• Wurster S, Bandi A, Beyda ND, et al. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris. J Antimicrob Chemother. 2019;74(7):1904–1910.
   PubMed Web of Science ®Google Scholar
• Arias LS, Butcher MC, Short B, et al. Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella infection model. Antimicrob Agents Chemother. 2020;64(8). DOI:10.1128/AAC.00476-20
   Web of Science ®Google Scholar
• Romera D, Aguilera-Correa JJ, García-Coca M, et al. The Galleria mellonella infection model as a system to investigate the virulence of Candida auris strains. Pathog Dis. 2020;78(9):ftaa067.
   PubMed Web of Science ®Google Scholar
• Johnson CJ, Davis JM, Huttenlocher A, et al. Emerging fungal pathogen Candida auris evades neutrophil attack. MBio. 2018;9(4):1–9.
   Web of Science ®Google Scholar
• Lima SL, Rossato L, Salles De Azevedo Melo A. Evaluation of the potential virulence of Candida haemulonii species complex and Candida auris isolates in Caenorhabditis elegans as an in vivo model and correlation to their biofilm production capacity. Microb Pathog. 2020;22:104461. 148.
   Google Scholar
• Gago S, García-Rodas R, Cuesta I, et al. Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the nonconventional host Galleria mellonella. Virulence. 2014;5(2):278–285.
   PubMed Web of Science ®Google Scholar
• Ames L, Duxbury S, Pawlowska B, et al. Galleria mellonella as a host model to study Candida glabrata virulence and antifungal efficacy. Virulence. 2017;8(8):1909–1917.
   PubMed Web of Science ®Google Scholar
• Ortega-Riveros M, De-la-pinta I, Marcos-Arias C, et al. Usefulness of the nonconventional Caenorhabditis elegans model to assess Candida virulence. Mycopathologia. 2017;182(9–10):785–795.
   PubMed Web of Science ®Google Scholar
• Hernando-Ortiz A, Mateo E, Ortega-Riveros M, et al. Caenorhabditis elegans as a model system to assess Candida glabrata, Candida nivariensis, and Candida bracarensis Virulence and Antifungal Efficacy. Antimicrob Agents Chemother. 2020;64(10):e00824–20.
   PubMed Web of Science ®Google Scholar
• Oksuz S, Sahin I, Yildirim M, et al. Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults. Jpn J Infect Dis. 2007;60(5):280–283.
   PubMed Web of Science ®Google Scholar
• Ade J, Silva AF, Rosa FC, et al. In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida. Rev Soc Bras Med Trop. 2011;44(3):334–338.
   PubMed Web of Science ®Google Scholar
• L’Ollivier C, Labruère C, Jebrane A, et al. Using a multi-locus microsatellite typing method improved phylogenetic distribution of Candida albicans isolates but failed to demonstrate association of some genotype with the commensal or clinical origin of the isolates. Infect Genet Evol. 2012;12(8):1949–1957.
   PubMed Web of Science ®Google Scholar
• Atalay MA, Koc AN, Demir G, et al. Investigation of possible virulence factors in Candida strains isolated from blood cultures. Niger J Clin Pract. 2015;18(1):52–55.
   PubMed Web of Science ®Google Scholar
• Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods. 2008;72(2):157–165.
   PubMed Web of Science ®Google Scholar
• Ramage G, VandeWalle K, Wickes BL, et al. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol. 2001;18(4):163–170.
   PubMedGoogle Scholar
• Polak A. Virulence of Candida albicans mutants. Mycoses. 1992;35(1–2):9–16.
   PubMed Web of Science ®Google Scholar
• Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982;20(1):7–14.
   PubMedGoogle Scholar
• Cassone A, De Bernardis F, Mondello F, et al. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis. 1987;156(5):777–783.
   PubMed Web of Science ®Google Scholar
• Luo G, Samaranayake LP, Yau JY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol. 2001;39(8):2971–2974.
   PubMed Web of Science ®Google Scholar
• Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun. 1994;62(11):5154–5156.
   PubMed Web of Science ®Google Scholar
• Breger J, Fuchs BB, Aperis G, et al. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 2007;3(2):e18.
   PubMed Web of Science ®Google Scholar
• Larkin E, Hager C, Chandra J, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of scy-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother. 2017;61(5):1–13.
   Web of Science ®Google Scholar
• Romera D, Aguilera-Correa JJ, Gadea I, et al. Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs. J Med Microbiol. 2019;68(9):1353–1358.
   PubMed Web of Science ®Google Scholar
• Short B, Brown J, Delaney C, et al. Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence. J Hosp Infect. 2019;103(1):92–96.
   PubMed Web of Science ®Google Scholar
• Tobouti PL, Casaroto AR, De Almeida RS, et al. Expression of secreted aspartyl proteinases in an experimental model of Candida albicans-associat ed denture stomatitis. J Prosthodont. 2016;25(2):127–134.
   PubMedGoogle Scholar
• Chatterjee S, Alampalli SV, Nageshan RK, et al. Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC Genomics. 2015;16(1):1–16.
   PubMedGoogle Scholar
• Mesa-Arango AC, Forastiero A, Bernal-Martínez L, et al. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med Mycol. 2013;51(5):461–472.
   PubMed Web of Science ®Google Scholar
• Scorzoni L, De Lucas MP, Mesa-Arango AC, et al. Antifungal efficacy during Candida krusei infection in nonconventional models correlates with the yeast in vitro susceptibility profile. PLoS One. 2013;8(3):e60047.
   PubMed Web of Science ®Google Scholar
• Kwon YJ, Shin JH, Byun SA, et al. Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping. J Clin Microbiol. 2019;57(4):e01624–18.
   PubMed Web of Science ®Google Scholar
• Jf M, Rm W, Shea T, et al. Chromosomal rearrangements and loss of subtelomeric adhesins linked to clade-specific phenotypes in Candida auris. bioRxiv preprint;2019doi: 10.1101/754143.
   Google Scholar
• Szekely A, Borman AM, Johnson EM. Candida auris isolates of the Southern Asian and South African lineages exhibit different phenotypic and antifungal susceptibility profiles in vitro. J Clin Microbiol. 2019;57(5):e02055–18.
   PubMed Web of Science ®Google Scholar